Use of Curcumin in Psoriasis


  • Veronica Di Nardo Department of Nuclear, Subnuclear and Radiation Physics, University of Rome “G. Marconi”, Rome
  • Serena Gianfaldoni University G. Marconi of Rome, Dermatology and Venereology, Rome
  • Georgi Tchernev Medical Institute of Ministry of Interior Department of General, Vascular and Abdominal Surgery, Sofia
  • Uwe Wollina Städtisches Klinikum Dresden, Department of Dermatology and Allergology, 01067 Dresden
  • Victoria Barygina Department of Biomedical Experimental and Clinical Sciences, University of Florence, Florence
  • Jacopo Lotti Department of Nuclear, Subnuclear and Radiation Physics, University of Rome “G. Marconi”, Rome
  • Farah Daaboul Institute of Dermatological and Regenerative Sciences, Florence
  • Torello Lotti University G. Marconi of Rome, Dermatology and Venereology, Rome



Psoriasis, Curcumin, Anti-inflammatory, Anti - oxidant, Efficacy, Safe profile


Curcumin is a polyphenol derived from the golden spice turmeric, which is widely used for different purposes, such as culinary spice and alimentary addictive, make - up and, finally, as a natural product for the treatment of different diseases, especially for the chronic inflammatory ones. Recently, curcumin has been proposed as a valid and safe therapeutic option for psoriasis.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Garodia P, Ichikawa H, Malani N, et Al. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol. 2007; 5: 25–37. PMid:17309811

Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Medica. 1991; 57(1):1–7. PMid:2062949

Gupta SC, Patchva S, Koh W, et Al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012; 39 (3): 283–99. PMid:22118895 PMCid:PMC3288651

Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937; 229: 619–21.

Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006; 78: 2081–2087. PMid:16413584

Kim EJ, Lewis DJ, Dabaja BS et Al. Curcumin for the treatment of tumor - stage mycosis fungoides. Dermatol Ther. 2017; 30(4).

Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto, ON: Churchill Livingstone, 2000.

Dixit VP, Jain P, Joshi SC. Hypolipidaemic effects of Curcuma longa L. and Nardostachys jatamansi, DC in triton-induced hyperlipidaemic rats. Indian J Physiol Pharmacol. 1988; 32: 299–304. PMid:3215683

Bundy R, Walker AF, Middleton RW, et al. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. J Altern Complement Med. 2004; 10: 1015–8. PMid:15673996

Hanai H, Sugimoto K. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des. 2009; 15: 2087–94. PMid:19519446

Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4: 807–18. PMid:17999464

Lotti T, Hercogova J, Prignano F. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Dermatol Ther. 2010; 23(2): 119-22. PMid:20415818

Goren A, Salafia A, McCoy J et al. Novel topical cream delivers safe and effective alternative to traditional psoriasis phototherapy. Dermatol Ther. 2014; 27(5):260-3. PMid:24773915

Lotti T, Hercogova J. Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11. Dermatol Ther. 2015; 28(1):1-2. PMid:25286191

Lotti T. Something new under the sun in the field of psoriasis? Dermatol Ther. 2010; 23(2):99-100. PMid:20415815

Farahnik B, Nakamura M, Singh RK et Al. The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy. Dermatol Ther (Heidelb). 2016; 6(3):315-24. PMid:27474030 PMCid:PMC4972736

Fioranelli M, Roccia MG, Lotti T. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis. Dermatol Ther. 2017; 30(5).

Barygina V., Becatti M, Soldi G, et Al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013; 18(3):100-6. PMid:23601139

Reddy S, Aggarwal BB. Curcumin is a non - ompetitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 1994; 341(1):19–22.

Heng MC, Song MK, Harker J, et al. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol. 2000; 143 (5): 937–49. PMid:11069500

Varma SR, Sivaprakasam TO, Mishra A, et Al. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Eyr J Pharmacol. 2017; 813: 33-41. PMid:28736282

Kang D, Luo L, Jiang W, et Al. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie. 2016; 123: 73-80. PMid:26826458

Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J A Acad Dermatol. 2008; 58(4):625–31. PMid:18249471 PMCid:PMC4131208

Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integr Med Comm, 2000: 379–84.

Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, ulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41(1):40–59. PMid:18662800 PMCid:PMC2637808



How to Cite

Di Nardo V, Gianfaldoni S, Tchernev G, Wollina U, Barygina V, Lotti J, Daaboul F, Lotti T. Use of Curcumin in Psoriasis. Open Access Maced J Med Sci [Internet]. 2018 Jan. 21 [cited 2024 Apr. 18];6(1):218-20. Available from:

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>